Quantrx Biomedical Valuation
| QTXBDelisted Stock | USD 0.0005 0.00 0.00% |
Quantrx Biomedical seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Quantrx Biomedical from analyzing the company fundamentals such as EBITDA of (43.38 K), return on asset of -2.1, and Shares Owned By Insiders of 18.74 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Quantrx Biomedical's price fluctuation is very steady at this time. Calculation of the real value of Quantrx Biomedical is based on 3 months time horizon. Increasing Quantrx Biomedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Quantrx Biomedical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Quantrx Pink Sheet. However, Quantrx Biomedical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.0E-4 | Real 4.25E-4 | Hype 5.0E-4 |
The real value of Quantrx Pink Sheet, also known as its intrinsic value, is the underlying worth of Quantrx Biomedical Company, which is reflected in its stock price. It is based on Quantrx Biomedical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Quantrx Biomedical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Quantrx Biomedical helps investors to forecast how Quantrx pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Quantrx Biomedical more accurately as focusing exclusively on Quantrx Biomedical's fundamentals will not take into account other important factors: Quantrx Biomedical Total Value Analysis
Quantrx Biomedical is at this time anticipated to have valuation of 3.21 M with market capitalization of 605.96 K, debt of 2.77 M, and cash on hands of 1.65 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Quantrx Biomedical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.21 M | 605.96 K | 2.77 M | 1.65 K |
Quantrx Biomedical Asset Utilization
One of the ways to look at asset utilization of Quantrx is to check how much profit was generated for every dollar of assets it reports. Quantrx Biomedical holds a negative application of assets of -2.1 pct., losing $0.021 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Quantrx Biomedical shows how discouraging it operates for each dollar spent on its assets.Quantrx Biomedical Ownership Allocation
Quantrx Biomedical owns a total of 78.7 Million outstanding shares. Quantrx Biomedical holds 18.74 pct. of its outstanding shares held by insiders and 0.0 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Quantrx Biomedical Profitability Analysis
Net Loss for the year was (260.04 K) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Quantrx Biomedical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Quantrx Biomedical and how it compares across the competition.
About Quantrx Biomedical Valuation
The pink sheet valuation mechanism determines Quantrx Biomedical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Quantrx Biomedical. We calculate exposure to Quantrx Biomedical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Quantrx Biomedical's related companies.QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads and PAD based over-the-counter products in the United States. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon. Quantrx Biomedical is traded on OTC Exchange in the United States.
8 Steps to conduct Quantrx Biomedical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Quantrx Biomedical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Quantrx Biomedical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Quantrx Biomedical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Quantrx Biomedical's revenue streams: Identify Quantrx Biomedical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Quantrx Biomedical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Quantrx Biomedical's growth potential: Evaluate Quantrx Biomedical's management, business model, and growth potential.
- Determine Quantrx Biomedical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Quantrx Biomedical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Quantrx Biomedical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 78.7 M | |
| Retained Earnings | -52.4 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in median. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Quantrx Pink Sheet
If you are still planning to invest in Quantrx Biomedical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Quantrx Biomedical's history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |